Is It Time To Reassess Ocular Therapeutix (OCUL) After Its Recent Share Price Slide [Yahoo! Finance]
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: Yahoo! Finance
If you are wondering whether Ocular Therapeutix at around US$8.68 is a bargain or a value trap, the key is understanding what the current price actually implies. The stock is down 12.1% over the last week and 2.3% over the last month, while still showing a 16.5% return over 1 year and 69.2% over 3 years, set against a 26.6% decline year to date and a 53.3% decline over 5 years. Recent attention on Ocular Therapeutix has centered on its position within the US pharmaceuticals and biotech space, including how the market weighs its pipeline prospects against funding needs and execution risks. This backdrop helps explain why the share price can swing sharply as sentiment around its clinical and commercial milestones shifts. Simply Wall St currently assigns Ocular Therapeutix a valuation score of 2 out of 6 , which will be unpacked using different valuation methods next, along with a look at a broader way to think about what the market is pricing in. Ocular Therapeutix scores just
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Avoid OCUL and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL) [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Ocular Therapeutix, Inc. (OCUL) Discusses Phase III SOL-1 Data Highlighting Transformative Durability in Wet AMD Transcript [Seeking Alpha]Seeking Alpha
OCUL
Earnings
- 11/4/25 - Beat
OCUL
Sec Filings
- 2/27/26 - Form 8-K
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- OCUL's page on the SEC website